Company TaiRx, Inc.

Equities

6580

TW0006580004

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
38.45 ^TWD	+0.26%		+1.59%	+42.41%

Apr. 11	TaiRx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	TaiRx, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

TaiRx Inc is a Taiwan-based company mainly engaged in the development and research of new drugs. The Company primarily focus on the research and development of cancer treatment drugs and sepsis adjuvant therapy drugs. The Company's main products include CVM-1118, Rexis, Zelnite, TRX-NOC, TRX-920, TRX-711, TRX-105 and others. CVM-1118 and Rexis are in clinical trials, and Zelnite drugs are sold to domestic medical institutions at all levels through distributors.

TWD in Million	2022	Weight	2023	Weight	Delta
Medical Drugs and Other Related Products 100.0 %	7	100.0 %	5	100.0 %	-26.59%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 100.0 %	7	100.0 %	5	100.0 %	-26.59%

Managers	Title	Age	Since
Yi Wen Chu FOU	Founder	-	11-08-21
Du Shieng Chien CEO	Chief Executive Officer	-	11-08-21
Jackson Huang DFI	Director of Finance/CFO	-	15-10-04
Harry Olson PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Du Shieng Chien CEO	Chief Executive Officer	-	11-08-21
Yi Wen Chu FOU	Founder	-	11-08-21
Hsiu Hui Li BRD	Director/Board Member	-	11-08-21
Hsien Shou Kuo BRD	Director/Board Member	82	19-09-01
Sheng Chu Kuo BRD	Director/Board Member	-	11-08-21
Tien Shang Wu BRD	Director/Board Member	-	19-05-15
Ku Tung Lin BRD	Director/Board Member	-	16-12-14
Chia Hsiang Chang BRD	Director/Board Member	71	16-12-14
Chih Hua Shen BRD	Director/Board Member	-	15-06-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	110,199,908	58,397,604 ( 52.99 %)	0	52.99 %

TaiRx, Inc.

Nankang Business Park 6F-1, No. 66 Sanchung Road

115 02, Taipei

http://www.trx.com.tw/

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
TAIRX, INC.	+42.41%	130M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+48.71%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research